Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
Akero Therapeutics Inc (NASDAQ: AKRO) closed the day trading at $26.61 down -3.73% from the previous closing price of $27.64. In other words, the price has decreased by -$3.73 from its previous closing price. On the day, 1.14 million shares were traded. AKRO stock price reached its highest trading level at $28.205 during the session, while it also had its lowest trading level at $26.245.
Ratios:
For a better understanding of AKRO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Citigroup on November 18, 2024, initiated with a Buy rating and assigned the stock a target price of $65.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.Cantor Fitzgerald initiated its Overweight rating on September 19, 2023, with a $69 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 02 ’25 when Young Jonathan sold 10,000 shares for $28.03 per share. The transaction valued at 280,330 led to the insider holds 218,083 shares of the business.
Jonathan Young bought 70,000 shares of AKRO for $1,947,400 on Jan 02 ’25. On Dec 16 ’24, another insider, Lamy Patrick, who serves as the Senior VP, Commercial Strategy of the company, sold 1,000 shares for $29.13 each. As a result, the insider received 29,130 and left with 34,258 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1857356800 and an Enterprise Value of 1176467328.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $37.00, while it has fallen to a 52-week low of $15.32. The 50-Day Moving Average of the stock is -12.57%, while the 200-Day Moving Average is calculated to be 2.58%.
Shares Statistics:
Over the past 3-months, AKRO traded about 599.60K shares per day on average, while over the past 10 days, AKRO traded about 695200 shares per day. A total of 69.61M shares are outstanding, with a floating share count of 58.30M. Insiders hold about 16.48% of the company’s shares, while institutions hold 96.81% stake in the company. Shares short for AKRO as of 1734048000 were 3298482 with a Short Ratio of 5.50, compared to 1731628800 on 3624838. Therefore, it implies a Short% of Shares Outstanding of 3298482 and a Short% of Float of 4.8699997.
